| Serial Number | 79362259 |
| Word Mark | XPERT ALLIANCE RENTSCHLER & VETTER SUBSTANCE PRODUCT PATIENT |
| Filing Date | Monday, May 23, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 26, 2024 |
| Registration Number | 7334071 |
| Registration Date | Tuesday, March 26, 2024 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 9, 2024 |
| Goods and Services | Contract manufacturing in the field of pharmaceuticals and pharmaceutical substances; custom manufacture of veterinary preparations and substances; custom manufacture of diagnostic preparations and substances for medical and veterinary use; custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; consultancy services relating to custom manufacturing process services; assembly of products for others, custom manufacture and assembly services, custom assembly for others of electronic components for medical devices and apparatus, semiconductor components and circuit switches; consultancy and information for the customised manufacture and production processes for electronic components, semi-conductor components and circuits for medical apparatus and equipment |
| Description of Mark | The mark consists of the stacked wording "XPERT ALLIANCE" in blue. To the right of the term "XPERT" appears the wording "RENTSCHLER" in orange above the wording "& VETTER" in orange. All the aforesaid appears above the wording "SUBSTANCE PRODUCT PATIENT" in black with these terms separated by orange triangles. |
| Goods and Services | Bottling services and storage of goods in the nature of liquid and solid substances, especially, pharmaceuticals, medicines and solutions, for others |
| Pseudo Mark | EXPERT ALLIANCE RENTSCHLER AND VETTER SUBSTANCE PRODUCT PATIENT |
| Indication of Colors claimed | The color(s) black, blue, and orange is/are claimed as a feature of the mark. |
| Goods and Services | Medical services; medical assistance; animal healthcare services, namely, animal breeding, animal grooming, medical analysis services for diagnostic and treatment purposes; consultancy and information services relating to biopharmaceutical products, namely, providing medical information and pharmaceutical consultation in the nature of a medical consultation relating to biopharmaceutical products |
| NOT AVAILABLE | "EXPERT ALLIANCE" |
| Goods and Services | Scientific and technological services, namely, scientific research, analysis, testing and development in the field of biomanufacturing and in the pharmaceutical field and research and design relating thereto; industrial analysis and research services, namely, chemical, biochemical, biological and bacteriological research and analysis and industrial research in the field of pharmaceuticals; chemistry services, namely, chemistry consultation, research in the fields of chemistry; biochemical services, namely, biochemistry consultation, research in the fields of biochemistry; services of medical, bacteriological and chemical laboratories, namely, laboratory research and laboratory analysis; research on the subject of pharmaceuticals; biochemistry research services; development of pharmaceutical, veterinary and diagnostic products and substances and methods for the manufacture thereof, in particular using biotechnological and genetically-engineered means, in the nature of research in the field of manufacturing machinery for pharmaceutical, veterinary and diagnostic products and substances, design and development of computer hardware for the pharmaceutical, veterinary and diagnostic products and substances manufacturing industries; technological consultancy relating to pharmacy, namely, consulting services in the field of pharmaceutical research and development, technical consulting in the field of pharmaceutical studies; technological consultancy in the veterinary research field; technological consultancy in the field of diagnostics, namely, consulting services in the field of pharmaceutical research and development, consulting services in the field of pharmacogenetics; quality control for others; providing information and data relating to medical research and development; development of syringes and instruments for injections, injectors and packaging for the aforesaid goods for others; product quality and product safety testing, namely, chemical testing, physical testing and process engineering testing, in particular laboratory testing; pharmacological and microbiological development, research and analysis for others; conducting clinical tests, namely, scientific research in the nature of conducting clinical trials for others; conducting technical project studies in the nature of scientific feasibility studies and technological support services being technological research in the field of pharmaceutical agent manufacturing processes and pharmaceutical co-filling and packaging processes; industrial manufacturing process development consultancy |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 10, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 039 - Transport; packaging and storage of goods; travel arrangement. |
| US Class Codes | 100, 105 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 10, 2023 |
| Primary Code | 039 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 10, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 10, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Rentschler Biopharma SE |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Party Name | Vetter Pharma-Fertigung GmbH & Co. KG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 28 - NOT AVAILABLE |
| Address | DE |
| Party Name | Rentschler Biopharma SE |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Party Name | Vetter Pharma-Fertigung GmbH & Co. KG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 28 - NOT AVAILABLE |
| Address | DE |
| Party Name | Rentschler Biopharma SE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Party Name | Vetter Pharma-Fertigung GmbH & Co. KG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 28 - NOT AVAILABLE |
| Address | DE |
| Event Date | Event Description |
| Thursday, February 9, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, February 10, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, February 14, 2023 | APPLICATION FILING RECEIPT MAILED |
| Saturday, March 11, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, March 21, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 22, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, May 11, 2023 | REFUSAL PROCESSED BY MPU |
| Friday, May 12, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, June 7, 2023 | REFUSAL PROCESSED BY IB |
| Thursday, November 9, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, November 9, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, November 9, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 5, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, December 5, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, December 5, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, December 5, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, December 5, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 20, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, December 20, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, December 20, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Tuesday, January 9, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 26, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 26, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Thursday, June 27, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, January 8, 2024 | NOTIFICATION PROCESSED BY IB |
| Tuesday, January 9, 2024 | PUBLISHED FOR OPPOSITION |